ProAssurance downgraded by Piper Sandler with a new price target
$PRA
Property-Casualty Insurers
Finance
Piper Sandler downgraded ProAssurance from Overweight to Neutral and set a new price target of $18.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/10/2025 | Mkt Perform → Underperform | Raymond James | |
| 4/3/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | |
| 11/11/2024 | $18.00 | Overweight → Neutral | Piper Sandler |
| 2/24/2023 | $21.00 | Neutral | Janney |
| 8/10/2021 | $23.00 → $26.00 | Neutral → Overweight | Piper Sandler |
PICA Group, part of the ProAssurance family of companies, announced today the retirement of Dr. Ross E. Taubman, DPM. effective March 31, 2024, after 12 years of dedicated service. During his tenure, Dr. Taubman has been a valuable leader of the PICA Group team, overseeing PICA and OUM since he joined the company in 2011, as well as assuming responsibility as the head of PICA Group's additional business units, DentistCare and LawyerCare, in 2019. Throughout his time as President, Dr. Taubman demonstrated exceptional strategic vision and a passion for innovation. His commitment has helped PICA Group expand its market presence and deliver exceptional results. Under his guidance, PICA has
BIRMINGHAM, Ala.--(BUSINESS WIRE)--The Board of Directors of ProAssurance Corporation (NYSE:PRA) has declared a cash dividend of $0.05 per common share, payable on January 7, 2021 to shareholders who own our stock as of December 22, 2020. For 2020, our dividend policy anticipates a total annual dividend of $0.72 per share. On an annualized basis going forward, our policy anticipates annual dividends of $0.20 per share to be paid in equal quarterly installments. However, any decision to pay future cash dividends will be subject to the Board’s final determination after a comprehensive review of the company’s financial performance, future expectations, and other factors deemed relev
Raymond James downgraded ProAssurance from Mkt Perform to Underperform
Citizens JMP downgraded ProAssurance from Mkt Outperform to Mkt Perform
Piper Sandler downgraded ProAssurance from Overweight to Neutral and set a new price target of $18.00
AM Best has commented that the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of "a+" (Excellent) of the members of ProAssurance Group (ProAssurance) are unchanged following the March 19, 2025, announcement that all outstanding shares of ProAssurance Corporation (PRA) (NYSE:PRA) (Birmingham, AL) will be acquired by The Doctors Company Insurance Group (TDC Group). The outlook of ProAssurance's Credit Ratings (ratings) is stable. The ratings reflect ProAssurance's balance sheet strength, which AM Best assesses as strongest, as well as its adequate operating performance, favorable business profile and appropriate enterprise risk management. ProAssurance is
AM Best has commented that the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the members of The Doctors Company Insurance Group (TDC Group) (Napa, CA) are unchanged following the March 19, 2025, announcement that TDC Group will acquire all outstanding shares of ProAssurance Corporation (PRA) (NYSE:PRA) (Birmingham, AL). The outlook of TDC Group's Credit Ratings (ratings) is stable. The ratings reflect TDC Group's balance sheet strength, which AM Best assesses as strongest, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management. TDC Group is the second-la
Addition of ProAssurance Corporation fortifies the promise of The Doctors Company to the medical professional liability market for generations to come The Doctors Company, the nation's largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers' compensation insurance, today announced that they have entered into a definitive agreement under which ProAssurance will be acquired by The Doctors Company. Under the terms of the agreement, ProAssurance stockholders will receive $25.00 in cash per share, repr
ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability and a core small-cap value equity in the financials sector, today reported net income of $16.2 million, or $0.31 per diluted share, and operating income(1) of $18.3 million, or $0.36 per diluted share, for the three months ended December 31, 2024. For full-year 2024, ProAssurance reported net income of $52.7 million, or $1.03 per diluted share, and operating income(1) of $48.6 million, or $0.95 per diluted share. Fourth Quarter 2024(2) Highlights Specialty P&C segment combined ratio(1) of 100.9% demonstrates another quarter of progress from management's
Investor call to be held at 10:00 a.m. ET on Tuesday, February 25 ProAssurance Corporation (NYSE:PRA) will issue its news release and file its Form 10-K after the market closes on Monday, February 24, 2025. The release and 10-K will be available on the Company's website at investor.proassurance.com. ProAssurance will conduct its Fourth-Quarter and Full-Year 2024 quarterly conference call with analysts and investors to discuss the results and other information on Tuesday, February 25, 2025, at 10:00 a.m. ET. Preregistration for the call is available here and the dial-in numbers are (833) 470-1428 (toll free) or (404) 975-4839, access code 927016. Investors are encouraged to listen to t
ProAssurance Corporation (NYSE:PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability and a core small-cap value equity in the financials sector, today reported net income of $16.4 million, or $0.32 per diluted share, and operating income(1) of $17.3 million, or $0.34 per diluted share, for the three months ended September 30, 2024. Third Quarter 2024(2) Specialty P&C segment combined ratio of 99.5% demonstrates progress resulting from management's ongoing actions focused on achieving sustained profitability Net investment income increased 14% as we take advantage of the current interest rate environment as the portfolio matures Earning
4 - PROASSURANCE CORP (0001127703) (Issuer)
4 - PROASSURANCE CORP (0001127703) (Issuer)
4 - PROASSURANCE CORP (0001127703) (Issuer)
DEFA14A - PROASSURANCE CORP (0001127703) (Filer)
8-K - PROASSURANCE CORP (0001127703) (Filer)
8-K - PROASSURANCE CORP (0001127703) (Filer)
SC 13G/A - PROASSURANCE CORP (0001127703) (Subject)
SC 13G - PROASSURANCE CORP (0001127703) (Subject)
SC 13G - PROASSURANCE CORP (0001127703) (Subject)